Named patient programs
Governments worldwide have created provisions for granting access to drugs prior to approval for patients who have exhausted all alternative treatment options and do not match clinical trial entry criteria. Often grouped under the labels of compassionate use, expanded access, or named patient supply, these programs are governed by rules which vary by country defining access criteria, data collection, promotion, and control of drug distribution.
primaryTopic
Named patient programs
Governments worldwide have created provisions for granting access to drugs prior to approval for patients who have exhausted all alternative treatment options and do not match clinical trial entry criteria. Often grouped under the labels of compassionate use, expanded access, or named patient supply, these programs are governed by rules which vary by country defining access criteria, data collection, promotion, and control of drug distribution.
has abstract
Governments worldwide have cre ...... in the patient’s home country.
@en
Link from a Wikipage to an external page
Wikipage page ID
22,702,771
Wikipage revision ID
678,528,877
subject
comment
Governments worldwide have cre ...... control of drug distribution.
@en
label
Named patient programs
@en